162 related articles for article (PubMed ID: 7497599)
21. Combined efficacy of tamoxifen and coenzyme Q10 on the status of lipid peroxidation and antioxidants in DMBA induced breast cancer.
Perumal SS; Shanthi P; Sachdanandam P
Mol Cell Biochem; 2005 May; 273(1-2):151-60. PubMed ID: 16013450
[TBL] [Abstract][Full Text] [Related]
22. Regulation of estrogen receptor and epidermal growth factor receptor by tamoxifen under high and low estrogen environments in MCF-7 cells grown in athymic mice.
Koibuchi Y; Iino Y; Uchida T; Andoh T; Horii Y; Nagasawa M; Horiguchi J; Maemura M; Takei H; Yokoe T; Morishita Y
Oncol Rep; 2000; 7(1):135-40. PubMed ID: 10601607
[TBL] [Abstract][Full Text] [Related]
23. Effects of alterations in early hormonal environment on development and hormone dependency of carcinogen-induced mammary tumors in rats.
Sylvester PW; Aylsworth CF; Van Vugt DA; Meites J
Cancer Res; 1983 Nov; 43(11):5342-6. PubMed ID: 6413057
[TBL] [Abstract][Full Text] [Related]
24. Pharmacodynamics of tamoxifen and its 4-hydroxy and N-desmethyl metabolites: activation of caspases and induction of apoptosis in rat mammary tumors and in human breast cancer cell lines.
Mandlekar S; Hebbar V; Christov K; Kong AN
Cancer Res; 2000 Dec; 60(23):6601-6. PubMed ID: 11118041
[TBL] [Abstract][Full Text] [Related]
25. Biochemical and pharmacological effects of toremifene metabolites.
Kangas L
Cancer Chemother Pharmacol; 1990; 27(1):8-12. PubMed ID: 2147128
[TBL] [Abstract][Full Text] [Related]
26. [Effects of chemo-endocrine therapy on DMBA-induced rat mammary carcinoma].
Yamamoto H; Morimoto T; Monden A
Nihon Geka Gakkai Zasshi; 1989 Oct; 90(10):1786-92. PubMed ID: 2512479
[TBL] [Abstract][Full Text] [Related]
27. Potentiation of the antitumor effect of tamoxifen by combination with the antiprogestin onapristone.
Nishino T; Ishibashi K; Hirtreiter C; Nishino Y
J Steroid Biochem Mol Biol; 2009 Sep; 116(3-5):187-90. PubMed ID: 19500671
[TBL] [Abstract][Full Text] [Related]
28. Effects of OK-432 (Picibanil) on estrogen receptor levels and tamoxifen treatment in 7,12-dimethylbenz[a]anthracene-induced rat mammary cancers.
Iino Y; Ogawa T; Yoshida M; Izuo M; Takikawa H
Oncology; 1990; 47(2):185-90. PubMed ID: 2107482
[TBL] [Abstract][Full Text] [Related]
29. Cross-resistance of triphenylethylene-type antiestrogens but not ICI 182,780 in tamoxifen-stimulated breast tumors grown in athymic mice.
Lee ES; Schafer JM; Yao K; England G; O'Regan RM; De Los Reyes A; Jordan VC
Clin Cancer Res; 2000 Dec; 6(12):4893-9. PubMed ID: 11156249
[TBL] [Abstract][Full Text] [Related]
30. [Late phase II study of TAT-59 (miproxifene phospate) in advanced or recurrent breast cancer patients (a double-blind comparative study with tamoxifen citrate)].
Nomura Y; Nakajima M; Tominaga T; Abe O
Gan To Kagaku Ryoho; 1998 Jun; 25(7):1045-63. PubMed ID: 9644320
[TBL] [Abstract][Full Text] [Related]
31. 3,3'4,4'-Tetrachlorobiphenyl exhibits antiestrogenic and antitumorigenic activity in the rodent uterus and mammary cells and in human breast cancer cells.
Ramamoorthy K; Gupta MS; Sun G; McDougal A; Safe SH
Carcinogenesis; 1999 Jan; 20(1):115-23. PubMed ID: 9934858
[TBL] [Abstract][Full Text] [Related]
32. Tamoxifen-induced antitumorigenic/antiestrogenic action synergized by a selective aryl hydrocarbon receptor modulator.
McDougal A; Wormke M; Calvin J; Safe S
Cancer Res; 2001 May; 61(10):3902-7. PubMed ID: 11358803
[TBL] [Abstract][Full Text] [Related]
33. Effects of tamoxifen and melatonin on mammary gland cancer induced by N-methyl-N-nitrosourea and by 7,12-dimethylbenz(a)anthracene, respectively, in female Sprague-Dawley rats.
Kubatka P; Bojková B; M ciková-Kalická K; Mníchová-Chamilová M; Adámeková E; Ahlers I; Ahlersová E; Cermáková M
Folia Biol (Praha); 2001; 47(1):5-10. PubMed ID: 11232869
[TBL] [Abstract][Full Text] [Related]
34. Sequential hormone therapy with medroxyprogesterone acetate for 7, 12-dimethylbenz [alpha] anthracene-induced rat mammary tumors.
Iino Y; Ishikawa H; Izuo M; Takikawa H
Jpn J Clin Oncol; 1989 Mar; 19(1):45-50. PubMed ID: 2522157
[TBL] [Abstract][Full Text] [Related]
35. Inhibitory effect of the novel anti-estrogen EM-800 and medroxyprogesterone acetate on estrone-stimulated growth of dimethylbenz[a]anthracene-induced mammary carcinoma in rats.
Luo S; Stojanovic M; Labrie C; Labrie F
Int J Cancer; 1997 Nov; 73(4):580-6. PubMed ID: 9389575
[TBL] [Abstract][Full Text] [Related]
36. Potent inhibitory effect of a new antiestrogen (RU 16117) on the growth of 7,12-dimethylbenz[a]anthracene-induced rat mammary tumors.
Kelly PA; Asselin J; Caron MG; Labrie F; Raynaud JP
J Natl Cancer Inst; 1977 Mar; 58(3):623-8. PubMed ID: 402479
[TBL] [Abstract][Full Text] [Related]
37. Synthesis, biodistribution, and estrogen receptor scintigraphy of indium-111-diethylenetriaminepentaacetic acid-tamoxifen analogue.
Delpassand ES; Yang DJ; Wallace S; Cherif A; Quadri SM; Price J; Joubert A; Inoue T; Podoloff DA
J Pharm Sci; 1996 Jun; 85(6):553-9. PubMed ID: 8773948
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of the antitumour activity of the non-steroidal antioestrogen monohydroxytamoxifen in the DMBA-induced rat mammary carcinoma model.
Jordan VC; Allen KE
Eur J Cancer (1965); 1980 Feb; 16(2):239-51. PubMed ID: 6768559
[No Abstract] [Full Text] [Related]
39. Pharmacology of tamoxifen in laboratory animals.
Jordan VC; Allen KE; Dix CJ
Cancer Treat Rep; 1980; 64(6-7):745-59. PubMed ID: 6775807
[TBL] [Abstract][Full Text] [Related]
40. Antiestrogenic and antitumor properties of tamoxifen in laboratory animals.
Jordan VC
Cancer Treat Rep; 1976 Oct; 60(10):1409-19. PubMed ID: 828517
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
